We're continually updating our protocols in line with the latest scientific understanding, ensuring that as of 2026, our GHK-Cu peptides meet and exceed industry expectations for purity and stability
Comparing price differences between various branded options
Studies are also underway for a spectrum of other conditions, including Phase 3 trials investigating non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and obstructive sleep apnea (OSA), as well as mid-to-late stage trials exploring potential benefits in neurodegenerative disorders like Parkinsons disease
The Role and Importance of GLP-1 Supporting Insulin Release After eating, GLP-1 signals the pancreas to release insulin
Kinetic analysis of tyrosinase The mode of inhibition and inhibition parameters, i.e
Glutamate, Glycine and Cysteine